VESTAL POINT CAPITAL, LP
Adviser information for VESTAL POINT CAPITAL, LP last updated from Form ADV on March 27th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 10 |
---|---|
Investment Advisory/Research | 7 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 4 | $1.8B |
Non-Discretionary | 0 | $0 |
Total | 4 | $1.8B |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 3 | $736.3M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | <5 | $1.1B |
Type | Number |
---|---|
No. of Non-RAUM Clients | 4 |
No. of Non-U.S. Clients | 75 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
632 BROADWAYSUITE 602
NEW YORK
NY
United States
Monday - Friday, 8AM-5PM
Tel: 646-989-4000, Fax: None
Chief Compliance Officer
ILKO MENKOV
PARTNER & COO
632 BROADWAY
SUITE 602
NEW YORK
NY
United States
Tel:
646-989-4000
I**********@**************M
(Full email address available in API data)
Industry Affiliates
VESTAL POINT PARTNERS GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
VESTAL POINT MASTER FUND, LP | Hedge Fund | $736.3M | $1.0M | 33 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
WILDER, RYAN, CHRISTOPHER | Individual | – | MANAGING PARTNER AND CHIEF INVESTMENT OFFICER | 04/2023 | > 75% |
MENKOV, ILKO, LATCHEZAROV | Individual | – | PARTNER, COO AND CCO | 04/2023 | 5-10% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
Achilles Therapeutics PLC | SPONSORED ADS | 1M | 2M | – |
Allogene Therapeutics Inc | COM | 5M | 2M | – |
Alto Neuroscience Inc | COM SHS | 7M | 620K | – |
ALX Oncology Holdings Inc | COM | 22M | 4M | – |
Apellis Pharmaceuticals Inc | COM | 13M | 335K | – |
Applied Therapeutics Inc | COM | 25M | 5M | – |
Arcellx Inc | COMMON STOCK | 37M | 675K | – |
Ascendis Pharma A/S | SPONSORED ADR | 102M | 750K | – |
Astria Therapeutics Inc | COM | 30M | 3M | – |
Atara Biotherapeutics Inc | COM NEW | 952K | 112K | – |
Axsome Therapeutics Inc | COM | 24M | 300K | – |
BeiGene Ltd | SPONSORED ADR | 50M | 350K | – |
BioNTech SE | SPONSORED ADS | 8M | 100K | – |
Black Diamond Therapeutics Inc | COM | 10M | 2M | – |
Bristol-Myers Squibb Co | COM | 21M | 500K | – |
Chimerix Inc | COM | 1M | 1M | – |
Cytokinetics Inc | COM NEW | 112M | 2M | – |
Day One Biopharmaceuticals Inc | COM | 17M | 1M | – |
Denali Therapeutics Inc | COM | 12M | 500K | – |
Dianthus Therapeutics Inc | COM | 16M | 600K | – |
Dyne Therapeutics Inc | COM | 8M | 225K | – |
Exact Sciences Corp | COM | 39M | 925K | – |
Fate Therapeutics Inc | COM | 7M | 2M | – |
Fulcrum Therapeutics Inc | COM | 7M | 1M | – |
Galapagos NV | SPON ADR | 4M | 180K | – |
Globus Medical Inc | CL A | 62M | 900K | – |
Immatics NV | SHS | 32M | 3M | – |
Immunome Inc | COM | 12M | 1M | – |
Inari Medical Inc | COM | 17M | 350K | – |
Insmed Inc | COM PAR $.01 | 50M | 750K | – |
Inspire Medical Systems Inc | COM | 8M | 60K | – |
Iovance Biotherapeutics Inc | COM | 2M | 300K | – |
iTeos Therapeutics Inc | COM | 26M | 2M | – |
Janux Therapeutics Inc | COM | 30M | 725K | – |
Jazz Pharmaceuticals PLC | SHS USD | 160M | 2M | – |
KalVista Pharmaceuticals Inc | COM | 27M | 2M | – |
Lexeo Therapeutics Inc | COM | 13M | 840K | – |
Liquidia Corp | COM NEW | 22M | 2M | – |
MacroGenics Inc | COM | 3M | 800K | – |
Monte Rosa Therapeutics Inc | COM | 3M | 890K | – |
Newamsterdam Pharma Co NV | ORDINARY SHARES | 480K | 25K | – |
Nurix Therapeutics Inc | COM | 10M | 500K | – |
Pacira BioSciences Inc | COM | 8M | 280K | – |
Passage Bio Inc | COM | 5M | 6M | – |
Praxis Precision Medicines Inc | COM NEW | 18M | 440K | – |
Prime Medicine Inc | COM | 2M | 450K | – |
PTC Therapeutics Inc | COM | 3M | 90K | – |
Relmada Therapeutics Inc | COM | 4M | 1M | – |
Reneo Pharmaceuticals Inc | COM | 823K | 545K | – |
Savara Inc | COM | 26M | 6M | – |
Soleno Therapeutics Inc | COM | 49M | 1M | – |
Solid Biosciences Inc | COM NEW | 15M | 3M | – |
Structure Therapeutics Inc | SPONSORED ADS | 22M | 560K | – |
Ultragenyx Pharmaceutical Inc | COM | 74M | 2M | – |
uniQure NV | SHS | 21M | 5M | – |
Ventyx Biosciences Inc | COM | 3M | 1M | – |
Verve Therapeutics Inc | COM | 2M | 500K | – |
Voyager Therapeutics Inc | COM | 5M | 600K | – |
Xenon Pharmaceuticals Inc | COM | 20M | 525K | – |
Zymeworks Inc | COM | 4M | 440K | – |